{"id":"https://openalex.org/W1998110257","doi":"https://doi.org/10.1158/1538-7445.am2013-5098","title":"Abstract 5098: A mouse DLL4 cross-reactive variant of MEDI0639 disrupts functional vessel formation and inhibits tumor growth in preclinical models.","display_name":"Abstract 5098: A mouse DLL4 cross-reactive variant of MEDI0639 disrupts functional vessel formation and inhibits tumor growth in preclinical models.","publication_year":2013,"publication_date":"2013-04-01","ids":{"openalex":"https://openalex.org/W1998110257","doi":"https://doi.org/10.1158/1538-7445.am2013-5098","mag":"1998110257"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2013-5098","doi":"https://doi.org/10.1158/1538-7445.am2013-5098","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-5098","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081220114","display_name":"Song H. Cho","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Song H. Cho","raw_affiliation_strings":["1MedImmune, Gaithersbrug, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MedImmune, Gaithersbrug, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"David W. Jenkins","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David W. Jenkins","raw_affiliation_strings":["2AstraZeneca R&D Boston, Waltham, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AstraZeneca R&D Boston, Waltham, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079613331","display_name":"Patrick Strout","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick Strout","raw_affiliation_strings":["1MedImmune, Gaithersbrug, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MedImmune, Gaithersbrug, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081981073","display_name":"Martin Korade","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Korade","raw_affiliation_strings":["1MedImmune, Gaithersbrug, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MedImmune, Gaithersbrug, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075105240","display_name":"Haihong Zhong","orcid":"https://orcid.org/0000-0003-0721-3618","observed_orcids":["https://orcid.org/0000-0003-0721-3618"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haihong Zhong","raw_affiliation_strings":["1MedImmune, Gaithersbrug, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MedImmune, Gaithersbrug, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015608281","display_name":"Ching Ching Leow","orcid":"https://orcid.org/0009-0004-9542-0426","observed_orcids":["https://orcid.org/0009-0004-9542-0426"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ching Ching Leow","raw_affiliation_strings":["1MedImmune, Gaithersbrug, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MedImmune, Gaithersbrug, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083732009","display_name":"Shannon Breen","orcid":"https://orcid.org/0009-0006-0631-9831","observed_orcids":["https://orcid.org/0009-0006-0631-9831"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shannon Breen","raw_affiliation_strings":["1MedImmune, Gaithersbrug, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MedImmune, Gaithersbrug, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053918852","display_name":"Jon W. Chesebrough","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jon Chesebrough","raw_affiliation_strings":["1MedImmune, Gaithersbrug, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MedImmune, Gaithersbrug, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034002721","display_name":"Nicholas Holoweckyj","orcid":"https://orcid.org/0000-0001-6496-9900","observed_orcids":["https://orcid.org/0000-0001-6496-9900"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicholas Holoweckyj","raw_affiliation_strings":["1MedImmune, Gaithersbrug, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MedImmune, Gaithersbrug, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003411418","display_name":"Ivan V. Inigo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ivan Inigo","raw_affiliation_strings":["1MedImmune, Gaithersbrug, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MedImmune, Gaithersbrug, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111725868","display_name":"Gennady Gololobov","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gennady Gololobov","raw_affiliation_strings":["1MedImmune, Gaithersbrug, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MedImmune, Gaithersbrug, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057952505","display_name":"Ping Tsui","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ping Tsui","raw_affiliation_strings":["1MedImmune, Gaithersbrug, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MedImmune, Gaithersbrug, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090956456","display_name":"Kimberly E. Cook","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kimberly Cook","raw_affiliation_strings":["1MedImmune, Gaithersbrug, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MedImmune, Gaithersbrug, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088256361","display_name":"Melissa M. Damschroder","orcid":"https://orcid.org/0000-0001-9453-6532","observed_orcids":["https://orcid.org/0000-0001-9453-6532"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melissa Damschroder","raw_affiliation_strings":["1MedImmune, Gaithersbrug, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MedImmune, Gaithersbrug, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007107739","display_name":"Meggan Czapiga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meggan Czapiga","raw_affiliation_strings":["1MedImmune, Gaithersbrug, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MedImmune, Gaithersbrug, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056194172","display_name":"Philip Z. Brohawn","orcid":"https://orcid.org/0000-0002-7413-6539","observed_orcids":["https://orcid.org/0000-0002-7413-6539"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip Brohawn","raw_affiliation_strings":["1MedImmune, Gaithersbrug, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MedImmune, Gaithersbrug, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101477293","display_name":"Jiaqi Huang","orcid":"https://orcid.org/0000-0002-6514-3075","observed_orcids":["https://orcid.org/0000-0002-6514-3075"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jiaqi Huang","raw_affiliation_strings":["1MedImmune, Gaithersbrug, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MedImmune, Gaithersbrug, MD;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057347143","display_name":"Sally\u2010Ann Ricketts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sally-Ann Ricketts","raw_affiliation_strings":["3Astrazeneca, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Astrazeneca, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006565850","display_name":"Juliana Maynard","orcid":"https://orcid.org/0000-0003-1636-6595","observed_orcids":["https://orcid.org/0000-0003-1636-6595"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Juliana Maynard","raw_affiliation_strings":["3Astrazeneca, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Astrazeneca, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088377829","display_name":"Adeela Kamal","orcid":"https://orcid.org/0009-0000-0300-4961","observed_orcids":["https://orcid.org/0009-0000-0300-4961"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adeela Kamal","raw_affiliation_strings":["1MedImmune, Gaithersbrug, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1MedImmune, Gaithersbrug, MD;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"8_Supplement","first_page":"5098","last_page":"5098"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/delta-like-ligand-4","display_name":"DLL4","score":0.7400000095367432},{"id":"https://openalex.org/keywords/cross-reactive-antibodies","display_name":"cross-reactive antibodies","score":0.7300000190734863},{"id":"https://openalex.org/keywords/notch-signaling","display_name":"Notch signaling","score":0.7919999957084656},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.8199999928474426},{"id":"https://openalex.org/keywords/tumor-vasculature","display_name":"tumor vasculature","score":0.9079999923706055},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.777999997138977},{"id":"https://openalex.org/keywords/xenograft-tumor-model","display_name":"xenograft tumor model","score":0.7480000257492065},{"id":"https://openalex.org/keywords/tumor-perfusion","display_name":"tumor perfusion","score":0.7440000176429749},{"id":"https://openalex.org/keywords/microvessel-density","display_name":"microvessel density","score":0.9739999771118164},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.7229999899864197},{"id":"https://openalex.org/keywords/tumor-vasculature-imaging","display_name":"tumor vasculature imaging","score":0.44699999690055847}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7376338839530945},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.649216890335083},{"id":"https://openalex.org/C161879069","wikidata":"https://www.wikidata.org/wiki/Q904082","display_name":"Notch signaling pathway","level":3,"score":0.5183485746383667},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5151097178459167},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.4963410496711731},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4957183599472046},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.49424222111701965},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.47258102893829346},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4720761775970459},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.4568636119365692},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4189392626285553},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3720492422580719},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3280455470085144},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.324592649936676},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24197256565093994},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2187427282333374},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1524859368801117},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2013-5098","doi":"https://doi.org/10.1158/1538-7445.am2013-5098","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-5098","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2131933367","https://openalex.org/W3095374417","https://openalex.org/W3021227184","https://openalex.org/W2423432333","https://openalex.org/W4248223841","https://openalex.org/W2198545326","https://openalex.org/W2966960773","https://openalex.org/W2076274098","https://openalex.org/W2273365201","https://openalex.org/W2013557040"],"abstract_inverted_index":{"Abstract":[0],"Delta-like":[1],"ligand":[2,9],"4":[3],"(DLL4)":[4],"is":[5],"a":[6,28,100,163,201],"membrane":[7],"bound":[8,83],"for":[10,14,295],"Notch":[11,134],"receptors":[12],"essential":[13],"functional":[15,273],"vessel":[16,274],"formation":[17,275],"during":[18],"development":[19],"and":[20,36,90,93,150,169,188,193,215,276],"angiogenesis.":[21],"We":[22],"have":[23],"shown":[24],"previously":[25],"that":[26],"MEDI0639,":[27],"human":[29,89,103,189],"anti-DLL4":[30,158],"antibody,":[31],"has":[32,47],"potent":[33],"in":[34,37,40,56,64,107,128,166,171,199,280],"vitro":[35],"vivo":[38,57],"activity":[39],"blocking":[41],"DLL4-Notch":[42],"interaction.":[43],"However,":[44],"because":[45],"MEDI0639":[46,66,111,271],"low":[48],"binding":[49,95],"affinity":[50,86],"to":[51,54,69,73,87,97,175],"mouse":[52,74,91,129,187,266],"DLL4,":[53],"enable":[55],"pharmacology":[58],"studies":[59],"using":[60,122],"xenograft":[61,105,154],"tumor":[62,145,172,218,278],"models":[63,106],"mice,":[65,109],"was":[67],"engineered":[68],"bind":[70],"more":[71],"strongly":[72],"DLL4.":[75,98],"The":[76],"resulting":[77],"affinity-optimized":[78],"variant":[79,112,269],"antibody":[80,113,142,192,198],"(anti-mDLL4":[81],"mAb)":[82],"with":[84],"high":[85],"both":[88],"DLL4":[92,190,211,267],"maintained":[94],"specificity":[96],"In":[99,147,179],"number":[101],"of":[102,118,132,153,186,196,208,210,217,270,286,291],"cancer":[104],"nude":[108],"the":[110,116,123,133,157,176,184,194,205,287,292],"markedly":[114],"inhibited":[115],"growth":[117,279],"tumors.":[119],"qRT-PCR":[120],"analysis":[121,152],"Fluidigm":[124],"platform":[125],"showed":[126,162],"decreases":[127],"genes":[130],"downstream":[131],"signaling":[135],"pathway":[136],"at":[137],"efficacious":[138],"doses,":[139],"indicating":[140],"on-target":[141],"effect":[143],"on":[144,213],"vasculature.":[146],"addition,":[148],"IHC":[149],"imaging":[151],"tumors":[155],"from":[156],"mAb":[159],"dosed":[160],"animals":[161],"dose-dependent":[164],"increase":[165],"microvessel":[167],"density":[168],"decrease":[170],"perfusion":[173],"compared":[174],"control":[177],"groups.":[178],"summary,":[180],"we":[181],"describe":[182],"here":[183],"generation":[185],"cross-reactive":[191,268],"utilization":[195],"this":[197],"demonstrating":[200],"positive":[202],"correlation":[203],"between":[204],"anticipated":[206],"mechanism":[207],"action":[209],"blockade":[212],"vasculature":[214],"inhibition":[216],"growth.":[219],"Citation":[220],"Format:":[221],"Song":[222],"H.":[223],"Cho,":[224],"David":[225],"W.":[226],"Jenkins,":[227],"Patrick":[228],"Strout,":[229],"Martin":[230],"Korade,":[231],"Haihong":[232],"Zhong,":[233],"Ching":[234,235],"Leow,":[236],"Shannon":[237],"Breen,":[238],"Jon":[239],"Chesebrough,":[240],"Nicholas":[241],"Holoweckyj,":[242],"Ivan":[243],"Inigo,":[244],"Gennady":[245],"Gololobov,":[246],"Ping":[247],"Tsui,":[248],"Kimberly":[249],"Cook,":[250],"Melissa":[251],"Damschroder,":[252],"Meggan":[253],"Czapiga,":[254],"Philip":[255],"Brohawn,":[256],"Jiaqi":[257],"Huang,":[258],"Sally-Ann":[259],"Ricketts,":[260],"Juliana":[261],"Maynard,":[262],"Adeela":[263],"Kamal.":[264],"A":[265],"disrupts":[272],"inhibits":[277],"preclinical":[281],"models.":[282],"[abstract].":[283],"In:":[284],"Proceedings":[285],"104th":[288],"Annual":[289],"Meeting":[290],"American":[293],"Association":[294],"Cancer":[296,306],"Research;":[297],"2013":[298],"Apr":[299],"6-10;":[300],"Washington,":[301],"DC.":[302],"Philadelphia":[303],"(PA):":[304],"AACR;":[305],"Res":[307],"2013;73(8":[308],"Suppl):Abstract":[309],"nr":[310],"5098.":[311],"doi:10.1158/1538-7445.AM2013-5098":[312]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}